Electroretinography is the smallest product line in the electro diagnostic equipment market, but it is growing faster than any other: 10.27% a year through 2034, compared with 6.49% for electrocardiography, the line that generates most of the industry's revenue. ERG revenue rises from USD 0.48 billion in 2025 to USD 1.18 billion by 2034, lifting its share of the total market from 3% to 4%, while electrocardiography's own share slips from 62% to roughly 60% over the same span. Electrocardiography still supplies most of the money moving through the sector; ERG is simply the part moving fastest.
Contrive Datum Insights sizes the global electro diagnostic equipment market at USD 16 billion in 2025, rising to USD 17.35 billion in 2026 and USD 29.55 billion by 2034, a compound annual growth rate of 6.88% for the forecast period. The new report segments that total by product type, end-user, portability, component and distribution channel, with regional detail through 2034.
Why ERG is outrunning the market
The study attributes the bulk of the market's growth to rising diagnostic test volumes tied to cardiac and neurological disease, and rates that driver's impact high. ERG, used to evaluate retinal function, sits downstream of the same expansion in diagnostic testing capacity, and its low starting base means added volume moves its growth rate more than it would move a larger line. The scenario range around the 2034 total illustrates how much of that growth still depends on adoption pace: a bull case of USD 32.51 billion assumes faster uptake of portable and software-enabled systems and quicker diagnostic-center buildout in Asia Pacific; a bear case of USD 26.89 billion assumes slower equipment-replacement cycles and continued reimbursement pressure in public health systems.
Where the growth sits regionally
North America holds 38% of 2025 revenue, USD 6.08 billion, and reaches USD 10.05 billion by 2034, even as its share of the global total declines. Asia Pacific moves in the opposite direction: its share climbs from 24% to 29% as revenue grows from USD 3.84 billion to USD 8.57 billion, and the United States alone accounts for USD 5.17 billion of 2025 revenue, 32.31% of the global figure. Middle East and Africa stays the smallest region across the forecast, holding at 6% of revenue in both 2025 and 2034.
Segment patterns elsewhere in the report echo the ERG-versus-ECG split: Diagnostic Centers grow fastest among end-users at 8.19%, ahead of the 55%-share Hospitals segment; Wearable and Ambulatory Monitors grow at 11.14%, well ahead of the Stationary and Cart-based Systems that hold 55% of 2025 revenue; and Online / E-commerce grows at 12.98% against Direct and Institutional Tenders' 58% share.
Electrocardiography is the counterweight to that pattern: at 62% of 2025 revenue, USD 9.92 billion, it is the largest product-type line and stays the largest through 2034 at roughly 60% of the total, but its own growth rate, 6.49%, trails the market's 6.88% average. Scale and speed do not move together in this market; the line with the most revenue is not the one adding it fastest.
The report is delivered as a PDF, with a free sample available on request.